Trump Drug Pricing Flaw & Gilead Deal: What to Know
A structural gap in Trump's most-favored nation drug pricing framework raises doubts, while Gilead Sciences makes a major autoimmune therapeutics acquisition.
By Robert Kim
most-favored nation
2 articles tagged "most-favored nation"
Trump Drug Pricing & GSK Asthma Inhaler Controversy 2026
The White House pushes most-favored-nation drug pricing legislation while a Senate report scrutinizes GSK's asthma inhaler discontinuation strategy.